Skip to main content

Attovia Therapeutics, Inc. insider trading

ATTONASDAQ
$17.17-0.62 (-3.49% today)

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Aug 5, 2026 to Oct 2, 2026. Price (-21.6%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flow

Key players

  • vGvenBio Global Strategic Fund IV, L.P.10% Owner9.1594%of company
  • AHAlamar HoldCo, LLC10% Owner7.0738%of company
  • CWColin WalshDirector6.6168%of company
  • SSanofi-Aventis10% Owner2.372%of company
  • ATAttovia Therapeutics, Inc.Chief Financial Officer1.2016%of company
  • PVPetter VeibyChief Scientific Officer0.2299%of company
  • ZOZaneta OdrowazChief Business Officer0.2262%of company
  • AYAngie YouDirector0.1158%of company
  • HCHubert ChenChief Medical Officer0.0065%of company
  • GSGoldman Sachs Group Inc/OfficerNot reportedof company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
ATTOColin WalshDirectorOpen market purchase$8.5M+19.8%$17.00$8.5MAug 6, 2026Aug 28, 2026
ATTOGoldman Sachs Group Inc/InsiderOpen market purchase$8.5M+19.8%$17.00$8.5MAug 6, 2026Aug 28, 2026
ATTOvenBio Global Strategic Fund IV, L.P.10% OwnerOpen market purchase$6.5M+10.1%$17.00$6.5MAug 6, 2026Aug 10, 2026
ATTOSanofi-Aventis10% OwnerOpen market purchase$5.1M+38.3%$17.00$5.1MAug 6, 2026Aug 7, 2026
ATTORedmile Group, LLC10% OwnerOpen market purchase$6.8M+22.7%$17.00$6.8MAug 6, 2026Aug 7, 2026
ATTORedmile Group, LLC10% OwnerOpen market purchase$3.4M+10.2%$17.00$3.4MAug 6, 2026Aug 7, 2026
ATTOFrazier Life Sciences XI, L.P.10% OwnerOpen market purchase$10M+10.6%$17.00$10MAug 6, 2026Aug 6, 2026
ATTOColin WalshDirectorOpen market sell$1.61M-100.0%$21.04$1.61MAug 5, 2026Aug 28, 2026
ATTOColin WalshDirectorOpen market sell$146K-10.8%$21.61$146KAug 5, 2026Aug 28, 2026
ATTOColin WalshDirectorOpen market sell$2.2K-0.2%$21.99$2.2KAug 5, 2026Aug 28, 2026
ATTOColin WalshDirectorOpen market sell$25.8K-1.8%$22.19$25.8KAug 5, 2026Aug 28, 2026
ATTOColin WalshDirectorOpen market sell$15.4K-1.1%$22.07$15.4KAug 5, 2026Aug 28, 2026
ATTOColin WalshDirectorOpen market sell$4.41K-0.3%$22.05$4.41KAug 5, 2026Aug 28, 2026
ATTOColin WalshDirectorOpen market sell$9.65K-0.7%$21.78$9.65KAug 5, 2026Aug 28, 2026
ATTOColin WalshDirectorOpen market sell$6.25K-0.5%$20.84$6.25KAug 5, 2026Aug 28, 2026
ATTOColin WalshDirectorOpen market sell$22.9K-1.6%$22.05$22.9KAug 5, 2026Aug 28, 2026
ATTOColin WalshDirectorOpen market sell$25.8K-1.8%$21.84$25.8KAug 5, 2026Aug 28, 2026
ATTOColin WalshDirectorOpen market sell$8.81K-0.6%$22.02$8.81KAug 5, 2026Aug 28, 2026
ATTOColin WalshDirectorOpen market sell$154K-9.3%$22.03$154KAug 5, 2026Aug 28, 2026
ATTOColin WalshDirectorOpen market sell$14.8K-0.9%$22.02$14.8KAug 5, 2026Aug 28, 2026
ATTOColin WalshDirectorOpen market sell$16.5K-1.0%$21.97$16.5KAug 5, 2026Aug 28, 2026
ATTOColin WalshDirectorOpen market sell$2.21K-0.1%$22.11$2.21KAug 5, 2026Aug 28, 2026
ATTOColin WalshDirectorOpen market sell$10.3K-0.6%$21.55$10.3KAug 5, 2026Aug 28, 2026
ATTOColin WalshDirectorOpen market sell$4.42K-0.3%$22.10$4.42KAug 5, 2026Aug 28, 2026
ATTOColin WalshDirectorOpen market sell$74.9K-4.2%$22.02$74.9KAug 5, 2026Aug 28, 2026
ATTOColin WalshDirectorOpen market sell$34.3K-1.9%$22.06$34.3KAug 5, 2026Aug 28, 2026
ATTOColin WalshDirectorOpen market sell$4.41K-0.2%$22.05$4.41KAug 5, 2026Aug 28, 2026
ATTOColin WalshDirectorOpen market sell$29.3K-1.6%$22.03$29.3KAug 5, 2026Aug 28, 2026
ATTOColin WalshDirectorOpen market sell$9.78K-0.5%$21.87$9.78KAug 5, 2026Aug 28, 2026
ATTOColin WalshDirectorOpen market sell$21.8K-1.2%$22.03$21.8KAug 5, 2026Aug 28, 2026
ATTOColin WalshDirectorOpen market purchase$1.79MNot reported$21.00$1.79MAug 5, 2026Aug 28, 2026
ATTOGoldman Sachs Group Inc/InsiderOpen market sell$1.61M-100.0%$21.04$1.61MAug 5, 2026Aug 28, 2026
ATTOGoldman Sachs Group Inc/InsiderOpen market sell$146K-10.8%$21.61$146KAug 5, 2026Aug 28, 2026
ATTOGoldman Sachs Group Inc/InsiderOpen market sell$2.2K-0.2%$21.99$2.2KAug 5, 2026Aug 28, 2026
ATTOGoldman Sachs Group Inc/InsiderOpen market sell$25.8K-1.8%$22.19$25.8KAug 5, 2026Aug 28, 2026
ATTOGoldman Sachs Group Inc/InsiderOpen market sell$15.4K-1.1%$22.07$15.4KAug 5, 2026Aug 28, 2026
ATTOGoldman Sachs Group Inc/InsiderOpen market sell$4.41K-0.3%$22.05$4.41KAug 5, 2026Aug 28, 2026
ATTOGoldman Sachs Group Inc/InsiderOpen market sell$9.65K-0.7%$21.78$9.65KAug 5, 2026Aug 28, 2026
ATTOGoldman Sachs Group Inc/InsiderOpen market sell$6.25K-0.5%$20.84$6.25KAug 5, 2026Aug 28, 2026
ATTOGoldman Sachs Group Inc/InsiderOpen market sell$22.9K-1.6%$22.05$22.9KAug 5, 2026Aug 28, 2026
ATTOGoldman Sachs Group Inc/InsiderOpen market sell$25.8K-1.8%$21.84$25.8KAug 5, 2026Aug 28, 2026
ATTOGoldman Sachs Group Inc/InsiderOpen market sell$8.81K-0.6%$22.02$8.81KAug 5, 2026Aug 28, 2026
ATTOGoldman Sachs Group Inc/InsiderOpen market sell$154K-9.3%$22.03$154KAug 5, 2026Aug 28, 2026
ATTOGoldman Sachs Group Inc/InsiderOpen market sell$14.8K-0.9%$22.02$14.8KAug 5, 2026Aug 28, 2026
ATTOGoldman Sachs Group Inc/InsiderOpen market sell$16.5K-1.0%$21.97$16.5KAug 5, 2026Aug 28, 2026
ATTOGoldman Sachs Group Inc/InsiderOpen market sell$2.21K-0.1%$22.11$2.21KAug 5, 2026Aug 28, 2026
ATTOGoldman Sachs Group Inc/InsiderOpen market sell$10.3K-0.6%$21.55$10.3KAug 5, 2026Aug 28, 2026
ATTOGoldman Sachs Group Inc/InsiderOpen market sell$4.42K-0.3%$22.10$4.42KAug 5, 2026Aug 28, 2026
ATTOGoldman Sachs Group Inc/InsiderOpen market sell$74.9K-4.2%$22.02$74.9KAug 5, 2026Aug 28, 2026
ATTOGoldman Sachs Group Inc/InsiderOpen market sell$34.3K-1.9%$22.06$34.3KAug 5, 2026Aug 28, 2026
50 of 55 transactions

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.